相关实验视频

Updated: Jan 12, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

癌症丸抗原 (CTA) 在肺癌中

Chitrali Talele¹, Chintan Aundhia¹, Dipali Talele²

¹Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara 391760, Gujarat, India.

Clinica chimica acta; international journal of clinical chemistry

|November 1, 2025

概括

癌症丸抗原 (CTA) 显示出作为肺癌生物标志物的前景. 虽然有些,如NY-ESO-1,有局限性,但其他,如AKAP4,为早期诊断提供高灵敏度和特异性.

科学领域:

在瘤学瘤学.
生物标志物发现发现
分子诊断学分子诊断

背景情况:

肺癌仍然是全球癌症死亡的主要原因.
晚期诊断,归因于缺乏敏感和特定的生物标志物,显著影响生存率.
癌症丸抗原 (CTA) 越来越多地被认为具有作为恶性瘤相关生物标志物的潜力.

研究的目的:

审查癌症丸抗原 (CTA) 对肺癌的诊断潜力.
为了比较各种CTA (例如,NY-ESO-1,AKAP4) 与已建立的标记物的有效性.
讨论CTA测试在临床诊断工作流程中的整合及其在个性化医学中的作用.

主要方法:

对肺癌中CTAs现有研究的文献综述.
对不同CTA的诊断性能指标 (灵敏度,特异性) 的比较分析.
对CTA测定分析和预分析因素的评估.
评估CTA作为针对性治疗和免疫治疗的伴随诊断.

主要成果:

对于小细胞肺癌 (SCLC),NY-ESO-1自身抗体的特异性高 (90.9%),但敏感性低 (48.3%).
在周围血液单核细胞 (PBMC) 中的A-酶定蛋白4 (AKAP4) 定量PCR显示了对非小细胞肺癌 (NSCLC) 的高灵敏度 (92.8%) 和特异性 (92.6%).
各种CTA在肺癌亚型中表现出差异性的诊断效用.

结论:

CTAs代表了肺癌诊断的有前途的生物标志物类别, AKAP4等特定抗原显示出显著的潜力.
需要进一步的研究来应对临床翻译方面的挑战,包括试验标准化和验证.
CTA具有作为伴随诊断的潜力,以指导肺癌患者的免疫疗法和向治疗策略.

关键词:

生物标志物生物标志物癌症 / 测试抗原诊断诊断诊断诊断诊断肺癌肺癌是一种肺癌.治疗方法治疗方法

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Lung Tumor Cell Recruitment Assay

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....